MTOR and pancreatic neoplasm: Many mutated p53 forms can stimulate mechanistic target of rapamycin (mTOR) and block autophagic processes that could otherwise be tumor suppressive, leading to anti-apoptotic and pro-proliferative responses in breast and pancreatic cancer [64].